Share-based Payment Arrangement, Expense of NeuroPace Inc from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NeuroPace Inc quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • NeuroPace Inc Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2,628,000, a 1.4% increase year-over-year.
  • NeuroPace Inc Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $11,085,000, a 10% increase year-over-year.
  • NeuroPace Inc annual Share-based Payment Arrangement, Expense for 2024 was $10,282,000, a 7.6% increase from 2023.
  • NeuroPace Inc annual Share-based Payment Arrangement, Expense for 2023 was $9,558,000, a 14% increase from 2022.
  • NeuroPace Inc annual Share-based Payment Arrangement, Expense for 2022 was $8,349,000, a 95% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

NeuroPace Inc Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $11,085,000 $2,628,000 +$37,000 +1.4% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $11,048,000 $3,228,000 +$680,000 +27% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $10,368,000 $2,626,000 +$86,000 +3.4% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $10,282,000 $2,603,000 +$246,000 +10% 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
Q3 2024 $10,036,000 $2,591,000 +$170,000 +7% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 $9,866,000 $2,548,000 -$107,000 -4% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $9,973,000 $2,540,000 +$415,000 +20% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $9,558,000 $2,357,000 +$281,000 +14% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 $9,277,000 $2,421,000 +$239,000 +11% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $9,038,000 $2,655,000 +$52,000 +2% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $8,986,000 $2,125,000 +$637,000 +43% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 $8,349,000 $2,076,000 +$200,000 +11% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $8,149,000 $2,182,000 +$1,075,000 +97% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2023 Q3
Q2 2022 $7,074,000 $2,603,000 +$1,500,000 +136% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $5,574,000 $1,488,000 +$1,286,000 +637% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $4,288,000 $1,876,000 +$1,389,000 +285% 01 Oct 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 $2,899,000 $1,107,000 +$806,000 +268% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $2,093,000 $1,103,000 +$813,000 +280% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $1,280,000 $202,000 -$99,000 -33% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $1,379,000 $487,000 01 Oct 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 $301,000 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $290,000 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $301,000 01 Jan 2020 31 Mar 2020 10-Q 03 Jun 2021 2021 Q1

NeuroPace Inc Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $10,282,000 +$724,000 +7.6% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
2023 $9,558,000 +$1,209,000 +14% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
2022 $8,349,000 +$4,061,000 +95% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
2021 $4,288,000 +$2,909,000 +211% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
2020 $1,379,000 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.